NEW XELLIA GROUP A/S
Global leader in fermentation-based anti-infective pharmaceutical manufacturing and supply.
Oversikt
- 37
- Ansatte
- Ukjent
- Omsetning
- 2013
- Grunnlagt
Nøkkelbeslutningstakere
Steen Riisgaard
Chairman of the Board
Michael Kocher
Chief Executive Officer
Julie McHugh
Board Member
Vicente Oller
Chief Financial Officer
+11 flere kontakter i Funnelfeedr
Beskrivelse
Xellia Pharmaceuticals is a global leader in the development and manufacturing of fermentation-based, non-beta-lactam anti-infective medicines. With a rich legacy spanning over 120 years, the company provides essential Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) to more...